NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Hopewell Therapeutics

Hopewell Therapeutics

Private
Woburn, MassachusettsHealthcare & Life Scienceshttps://www.hopewell-tx.com/

Last Round

Seed

Jun 7, 2023

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Hopewell Therapeutics is a biotechnology company that develops tissue-targeted lipid nanoparticles (ttLNPs) for the systemic delivery of genomic medicines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

lipid nanoparticleLNPttLNPtissue-targeted lipid nanoparticledrug deliverygenomic medicineextrahepatic deliverymRNA deliverynon-viral deliveryionizable lipidbiotech platformdrug discoverynucleic acid deliverybiotech licensingprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hopewell Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Hopewell Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Hopewell Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 7, 2023

Hopewell Therapeutics Investors

Notable investors and investment history

Hopewell Therapeutics investors
InvestorRounds
Hike CapitalSeed
Mass Ave CapitalSeed
5Y CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 42% MoM.

  • Apr 16, 2026

    Monthly visitors increased 50% MoM.

Hopewell Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hopewell Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hopewell Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersWoburn, Massachusetts
Employee Range5
Year Founded2018
Last FundingJun 7, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.